Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis
- PMID: 27714455
- DOI: 10.1007/s00535-016-1273-2
Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis
Abstract
Hepatitis virus infection is a leading cause of chronic liver disease, including cirrhosis and hepatocellular carcinoma (HCC). Although anti-viral therapies against hepatitis B virus (HBV) and hepatitis C virus (HCV) have dramatically progressed during the past decade, the estimated number of people chronically infected with HBV and/or HCV is ~370 million, and hepatitis virus-associated hepatocarcinogenesis is a serious health concern worldwide. Understanding the mechanism of virus-associated carcinogenesis is crucial toward both treatment and prevention, and the recently developed whole genome/exome sequencing analysis using next-generation sequencing technologies has contributed to unveiling the landscape of genetic and epigenetic aberrations in not only tumor tissues but also the background liver tissues underlying chronic liver damage caused by hepatitis virus infection. Several major mechanisms underlie the genetic and epigenetic aberrations in the hepatitis virus-infected liver, such as the generation of reactive oxidative stress, ectopic expression of DNA mutator enzymes, and dysfunction of the DNA repair system. In addition, direct oncogenic effects of hepatitis virus, represented by the integration of HBV-DNA, are observed in infected hepatocytes. Elucidating the whole picture of genetic and epigenetic alterations, as well as the mechanisms of tumorigenesis, will facilitate the development of efficient treatment and prevention strategies for hepatitis virus-associated HCC.
Keywords: Cirrhosis; Hepatocarcinogenesis; Inflammation; Next-generation sequencing; Whole genome sequencing.
Similar articles
-
Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Oncotarget. 2016 May 3;7(18):25087-102. doi: 10.18632/oncotarget.7837. Oncotarget. 2016. PMID: 26943571 Free PMC article. Review.
-
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.J Gastroenterol. 2016 May;51(5):473-86. doi: 10.1007/s00535-015-1126-4. Epub 2015 Nov 9. J Gastroenterol. 2016. PMID: 26553052
-
Hepatitis virus infection affects DNA methylation in mice with humanized livers.Gastroenterology. 2014 Feb;146(2):562-72. doi: 10.1053/j.gastro.2013.10.056. Epub 2013 Oct 30. Gastroenterology. 2014. PMID: 24184133
-
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.Genomics. 2013 Aug;102(2):74-83. doi: 10.1016/j.ygeno.2013.04.001. Epub 2013 Apr 11. Genomics. 2013. PMID: 23583669 Review.
-
[Hepatitis B virus (HBV) infection and hepatocarcinogenesis].Orv Hetil. 2010 Jun 27;151(26):1045-53. doi: 10.1556/OH.2010.28881. Orv Hetil. 2010. PMID: 20558351 Review. Hungarian.
Cited by
-
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.Front Endocrinol (Lausanne). 2024 Mar 21;14:1286979. doi: 10.3389/fendo.2023.1286979. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38577257 Free PMC article. Review.
-
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives.World J Gastroenterol. 2022 Jul 21;28(27):3410-3421. doi: 10.3748/wjg.v28.i27.3410. World J Gastroenterol. 2022. PMID: 36158261 Free PMC article. Review.
-
Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers.Medeni Med J. 2022 Sep 21;37(3):255-263. doi: 10.4274/MMJ.galenos.2022.39049. Medeni Med J. 2022. PMID: 36128800 Free PMC article.
-
Genetic Landscape of Multistep Hepatocarcinogenesis.Cancers (Basel). 2022 Jan 23;14(3):568. doi: 10.3390/cancers14030568. Cancers (Basel). 2022. PMID: 35158835 Free PMC article. Review.
-
Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma.Front Med (Lausanne). 2021 Sep 30;8:754709. doi: 10.3389/fmed.2021.754709. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34660653 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous